+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07814248

Phase 1 Study of the Peptide Drug Conjugate TS-104 for Treatment of Select Advanced Solid Tumors

Led by TwoStep Therapeutics, Inc. · Updated on 2026-09-30

74

Participants Needed

3

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating an investigational drug called TS-104 in adults with select advanced solid tumors that have not improved with previous treatments. This Phase 1 study aims to determine a safe dose, understand side effects, assess how the drug is processed in the body, and evaluate its potential to treat these cancers. The study focuses on tumors like non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal, gastric, ovarian, and endometrial cancers. TS-104 is a peptide-drug conjugate designed to deliver the anticancer drug monomethyl auristatin E MMAE directly to tumor cells by targeting specific integrins commonly found on solid tumors. The study has two parts a dose escalation phase where researchers gradually increase doses to find the right level, and a dose expansion phase where one or more doses are tested in more participants. TS-104 is given either twice every three weeks or once every two weeks in treatment cycles lasting 21 or 28 days. Participants will receive TS-104 on one of these dosing schedules and will be closely monitored through regular assessments including scans and lab tests to track tumor response and side effects. Researchers will measure adverse events, dose-limiting toxicities, tumor response rates, progression-free survival, and overall survival, with follow-up continuing up to 26 months. The study is designed to carefully observe how participants tolerate the drug and how their cancer responds over time.

CONDITIONS

Brief Title

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Research Team

T

TwoStep Clinical Trials

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here